It’s the latest in a series of public offerings for Greater Washington life sciences companies.
Image: John Celebi is CEO of Sensei Biotherapeutics RICHARD PASLEY
{iframe}https://www.bizjournals.com/washington/news/2021/02/08/sensei-biotherapeutics-ipo-immunotherapy-biotech.html?ana=e_ae_prem&j=90549810&t=Afternoon&mkt_tok=eyJpIjoiWW1JeU9ERTBaR05oWVRaaCIsInQiOiIyYkVFSFwvXC9VcjR6QlwvWkRzOUF0NG5cL3Yrb3FmVFRDTCtFTnpzeTVLUEZXQis2a1pCRUp1R01Wdit0Y0lvOCtNQlZWR0RhQzRTM0tSVHlxMWQ0Z3ZcL1wvaFZBdU9mbzFQS1RHazFRTU11SjJnWWsxZlRodEtSK0wydlpLcjA0blR1RCJ9{/iframe}